<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wong TW</submitter><funding>Ministry of Science and Technology, Taiwan</funding><funding>National Cheng Kung University</funding><funding>National Cheng Kung University Hospital</funding><funding>Center of Applied Nanomedicine, National Cheng Kung University from the Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan</funding><funding>Chinese University of Hong Kong</funding><funding>Focused Investment Scheme and Li Ka Shing Institute of Health Science of the Chinese University of Hong Kong</funding><pagination>E1028</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6678880</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(7)</volume><pubmed_abstract>Human cardiac progenitor cells isolated from the same host may have advantages over other sources of stem cells. The aim of this study is to establish a new source of human progenitor cells collected from a waste product, pericardiac effusion fluid, after open-heart surgery in children with congenital heart diseases. The fluid was collected every 24 h for 2 days after surgery in 37 children. Mononuclear cells were isolated and expanded in vitro. These pericardial effusion-derived progenitor cells (PEPCs) exhibiting cardiogenic lineage markers, were highly proliferative and enhanced angiogenesis in vitro. Three weeks after stem cell transplantation into the ischemic heart in mice, cardiac ejection fraction was improved significantly without detectable progenitor cells. Gene expression profi</pubmed_abstract><journal>Journal of clinical medicine</journal><pubmed_title>Progenitor Cells Derived from Drain Waste Product of Open-Heart Surgery in Children.</pubmed_title><pmcid>PMC6678880</pmcid><funding_grant_id>101-2314-B-6-031, 102-2314-B-006-018, 103-2314-B-006-077</funding_grant_id><funding_grant_id>to H.C.C.</funding_grant_id><funding_grant_id>B106-K028, B107-K048</funding_grant_id><funding_grant_id>101-2314-B—6-031, 102-2314-B-006-018, 103-2314-B-006-077</funding_grant_id><funding_grant_id>10705004 to C.D.K.</funding_grant_id><funding_grant_id>972314B006018MY2, 106-2218-E-006-020</funding_grant_id><funding_grant_id>10703019</funding_grant_id><funding_grant_id>105-2628-B-006-003-MY3 to W.T.C.</funding_grant_id><funding_grant_id>1002627E033001, 1072321B006008</funding_grant_id><funding_grant_id>466710 to X.J.</funding_grant_id><funding_grant_id>10506007 to J.N.W.</funding_grant_id><funding_grant_id>to T.W.W.</funding_grant_id><pubmed_authors>Lin HC</pubmed_authors><pubmed_authors>Wang JN</pubmed_authors><pubmed_authors>Kao CC</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Lee YP</pubmed_authors><pubmed_authors>Lin CW</pubmed_authors><pubmed_authors>Chan HC</pubmed_authors><pubmed_authors>Kan CD</pubmed_authors><pubmed_authors>Chou CH</pubmed_authors><pubmed_authors>Ruan YC</pubmed_authors><pubmed_authors>Wong TW</pubmed_authors><pubmed_authors>Jiang X</pubmed_authors><pubmed_authors>Yu CK</pubmed_authors><pubmed_authors>Chen IY</pubmed_authors><pubmed_authors>Tsao S</pubmed_authors><pubmed_authors>Chiu WT</pubmed_authors><pubmed_authors>Fok KL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Progenitor Cells Derived from Drain Waste Product of Open-Heart Surgery in Children.</name><description>Human cardiac progenitor cells isolated from the same host may have advantages over other sources of stem cells. The aim of this study is to establish a new source of human progenitor cells collected from a waste product, pericardiac effusion fluid, after open-heart surgery in children with congenital heart diseases. The fluid was collected every 24 h for 2 days after surgery in 37 children. Mononuclear cells were isolated and expanded in vitro. These pericardial effusion-derived progenitor cells (PEPCs) exhibiting cardiogenic lineage markers, were highly proliferative and enhanced angiogenesis in vitro. Three weeks after stem cell transplantation into the ischemic heart in mice, cardiac ejection fraction was improved significantly without detectable progenitor cells. Gene expression profi</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jul</publication><modification>2026-05-07T06:42:29.231Z</modification><creation>2019-08-23T07:02:36Z</creation></dates><accession>S-EPMC6678880</accession><cross_references><pubmed>31336927</pubmed><doi>10.3390/jcm8071028</doi></cross_references></HashMap>